AskBorsa

SPINALEX results, Fiscal year 2021

Net profit, assets, equity and cash flow for Fiscal year 2021, against the same period a year earlier, from the published financial statements. fiscal year starts in July.

Net profit-41.88 millionEGP · −142.9% vs the same period a year earlier
Total assets718 millionEGP · −0.4% vs the same period a year earlier
Shareholders' equity564 millionEGP · −6.9% vs the same period a year earlier
Operating cash flow-15.56 millionEGP · +88.9% vs the same period a year earlier

In short

  • SPINALEX's net profit for Fiscal year 2021 was about -41.88 million EGP, down −142.9% from 97.6 million EGP in Fiscal year 2020.
  • Total assets at the end of Fiscal year 2021 were about 718 million EGP, and shareholders' equity about 564 million EGP.
  • Operating cash flow for Fiscal year 2021 was negative at 15.56 million EGP.
Source: the Fiscal year 2021 financial statements

Key lines against the same period a year earlier

This periodFiscal year 2020Change
Net profit-41.88 million97.6 million−142.9%
Gross profit12.77 million17.54 million−27.2%
Total assets718 million721 million−0.4%
Total liabilities154 million115 million+33.8%
Shareholders' equity564 million606 million−6.9%
Total liabilities and equity718 million721 million−0.4%
Operating cash flow-15.56 million-140 million+88.9%
Investing cash flow-43.37 million213 million−120.4%
Financing cash flow-8.87 million-7.01 million−26.5%
Net change in cash-58.92 million76.17 million−177.4%

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.

The report file for this period has not been published yet.All of SPINALEX's statements, five yearsAsk the AI analyst about SPIN

SPINALEX's Fiscal year 2026 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for SPINALEX